Functional Dyspepsia
Conditions
Interventions
rabeprazole
placebo
Sponsors
Office of CAESAR study
Group for CAESAR study
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with functional dyspepsia diagnosed according to the Rome III classification.
Exclusion criteria
Exclusion criteria: 1. Organic disease such as reflux esophagitis (> grade A) and erosive gastritis. 2. Patients with past history of gastrectomy 3. NSAIDs or low-dose aspirin -related dyspepsia 4. Patients with organic disease in the brain or with psychological disorders 5. Patients with alcoholics or with drug dependence 6. Severe endocrine disease including hyperthyroidism 7. Severe diseases in heart, liver and kidney. Severe infectious or hemotological diseases 8. Drug allegy for rabeprazole 9. expectant mother, mother with breast-feeding 10. other not applicable person recognized by a doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of dyspeptic symptoms by Gastrointestinal Symptoms Rating Scale (GSRS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Patients' Background QOL evaluation by SF-8 Anti-H. pylori IgG Serum pepsinogen I, pepsinogen II | — |
Countries
Japan
Contacts
Public ContactNaoki Tomotsugu, Ph.D.
Keio University School of Medicine Center for Clinical Research
Outcome results
None listed